v3.7.0.1

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash	$ 18,313	$ 20,542
Accounts receivable	8,795	11,724
Prepaid expenses		639
Total current assets	27,108	32,905
Other Asset
Intellectual assets, net of accumulated amortization of $90 and $60, respectively	210	240
TOTAL ASSETS	27,318	33,145
CURRENT LIABILITIES
Accounts payable and accrued expenses	98,133	138,134
Accrued interest	37,997	38,631
Notes payable, related party	35,000	35,000
Notes payable	15,000	5,000
Convertible notes payable, related party	112,157	112,157
Convertible notes payable	161,820	164,670
Other notes payable	16,500	35,000
Total current liabilities	476,607	528,592
TOTAL LIABILITIES	476,607	528,592
COMMITMENT AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Preferred stock, no par value, 1,000 shares authorized, 1,000 shares issued and outstanding as of June 30, 2017 and December 31, 2016	113,200	113,200
Common stock, $0.001 par value, 200,000,000 shares authorized, 3,979,792 and 3,312,273 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	3,980	3,312
Additional paid in capital	5,713,197	5,687,956
Stock subscription	23,000	23,000
Accumulated other comprehensive loss	(75,278)	(75,278)
Accumulated deficit	(6,227,388)	(6,247,637)
Total stockholders' deficit	(449,289)	(495,447)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 27,318	$ 33,145

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Glucose Health, Inc. 10-Q